Related Experiment Video
Updated: Jun 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in
Rolando Pajon1, Peter T Beernink, Lee H Harrison
1Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.
Abstract:
Meningococcal factor H-binding protein (fHbp) is a promising vaccine candidate that elicits serum bactericidal antibodies in humans. Based on sequence variability of the entire protein, fHbp has been divided into three variant groups or two sub-families. We recently reported that the fHbp architecture was modular, consisting of five variable segments, each encoded by genes from one of two lineages. Based on combinations of segments from different lineages, all 70 known fHbp sequence variants could be classified into one of six modular groups. In this study, we analyzed sequences of 172 new fHbp variants that were available from public databases. All but three variants could be classified into one of the six previously described modular groups. Among systematically collected invasive group B isolates from the U.S. and Europe, modular group I overall was most common (60%) but group IV (natural chimeras) accounted for 23% of UK isolates and <1% of U.S. isolates (P<0.0001). Mouse antisera to recombinant fHbp from each of the modular groups showed modular group-specific bactericidal activity against strains with low fHbp expression but had broader activity against strains with higher fHbp expression. Thus both modular group and relative expression of fHbp affected strain susceptibility to anti-fHbp bactericidal activity. The results confirmed the modular architecture of fHbp and underscored its importance for the design of broadly protective group B vaccines in different regions.
Insights
Meningococcal factor H-binding protein (fHbp) has a modular structure, crucial for designing effective group B vaccines. Understanding fHbp variants and their expression is key to developing broad protection against meningococcal disease.
Area of Science:
- Microbiology
- Vaccinology
- Immunology
Background:
- Meningococcal factor H-binding protein (fHbp) is a key vaccine target.
- fHbp exhibits sequence variability, classified into groups and sub-families.
- Previous work established a modular architecture for fHbp.
Purpose of the Study:
- To analyze new fHbp variants and classify them based on modular architecture.
- To investigate the prevalence of different fHbp modular groups in invasive meningococcal disease isolates.
- To assess the impact of fHbp modular groups and expression levels on vaccine-induced bactericidal activity.
Main Methods:
- Sequence analysis of 172 new fHbp variants from public databases.
- Classification of variants into previously defined modular groups.
- Analysis of invasive group B isolates from the U.S. and Europe.
- Testing mouse antisera against recombinant fHbp from different modular groups.
Main Results:
- 172 new fHbp variants were classified into six previously defined modular groups.
- Modular group I was most common overall, while group IV was prevalent in UK isolates but rare in U.S. isolates.
- Antisera showed modular group-specific activity against low-expressing strains and broader activity against high-expressing strains.
Conclusions:
- The modular architecture of fHbp is confirmed.
- Both modular group and fHbp expression influence susceptibility to bactericidal antibodies.
- Understanding fHbp modularity is vital for designing broadly protective group B vaccines regionally.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Clinical Significance of Antibiotic Resistance
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Regulation of Bacterial Virulence

